{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:11:47Z","timestamp":1789560707527,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgeb.2026.100733","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:24:27Z","timestamp":1782249867000},"page":"100733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["MMP-9 and non-invasive markers in evaluating MASLD and atherosclerosis"],"prefix":"10.1016","volume":"24","author":[{"given":"Ghada M.","family":"Salum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Abd el Meguid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma E.","family":"Fotouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Mokhles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham Ibrahim","family":"siddik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif Hassan","family":"Elwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham M.","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jgeb.2026.100733_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21194","article-title":"HCV treatment outcome depends on SNPs of IFNL3-Gene polymorphisms (rs12979860) and cirrhotic changes in liver parenchyma","volume":"9","author":"Abd Alla","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100733_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-021-02038-3","article-title":"FIB-4, APRI, and AST\/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran","volume":"21","author":"Amernia","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1016\/j.jgeb.2026.100733_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers14071847","article-title":"MMP9: A tough target for targeted therapy for cancer","volume":"14","author":"Augoff","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.jgeb.2026.100733_bb0020","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.transproceed.2007.06.046","article-title":"Down-regulation of matrix metalloproteinase-9 (MMP-9) expression in the myocardium of congestive heart failure patients","volume":"39","author":"Batlle","year":"2007","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100733_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14309\/ctg.0000000000000023","article-title":"Liver stiffness measurement with fibroscan: use the right probe in the right conditions!","volume":"10","author":"Berger","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"issue":"12","key":"10.1016\/j.jgeb.2026.100733_bb0030","doi-asserted-by":"crossref","first-page":"735","DOI":"10.12659\/MSM.883601","article-title":"The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease","volume":"18","author":"Cichoz-Lach","year":"2012","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100733_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56235-y","article-title":"FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis","volume":"9","author":"Coilly","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgeb.2026.100733_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156714","article-title":"Evaluation of the expression of fibrosis-related genes as non-invasive diagnostic biomarkers for cirrhotic HCV-infected patients","volume":"182","author":"El-Meguid","year":"2024","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100733_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2025.117105","article-title":"Evaluation of PNPLA3 genetic variants in Egyptian HBV-infected patients concomitant with metabolic-associated steatotic liver disease (MASLD)","volume":"114","author":"El-Meguid","year":"2025","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100733_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s43066-021-00115-6","article-title":"Validity of routine biochemical and ultrasound scores for prediction of hepatic fibrosis and steatosis in NAFLD","volume":"11","author":"Eletreby","year":"2021","journal-title":"Egypt Liver J"},{"key":"10.1016\/j.jgeb.2026.100733_bb0055","first-page":"374","article-title":"Erratum: EASL-EASD-EASO clinical practice guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (Obes Facts. (2024) 17: 4 (374-444) DOI: 10.1159\/000539371)","volume":"443","author":"Facts","year":"2024","journal-title":"Obes Facts"},{"key":"10.1016\/j.jgeb.2026.100733_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2025.110872","article-title":"Clinical impact of PTEN rs701848 as a predictive marker for breast cancer","volume":"136","author":"Fotouh","year":"2025","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100733_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/sjg.sjg_357_21","article-title":"The egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"28","author":"Fouad","year":"2022","journal-title":"Saudi J Gastroenterol"},{"issue":"1212","key":"10.1016\/j.jgeb.2026.100733_bb0070","first-page":"2","article-title":"Matrix metalloproteinases as potential biomarkers","volume":"9","author":"Geervliet","year":"2020","journal-title":"J Cells"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100733_bb0075","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s12072-023-10530-z","article-title":"Furthering research on MAFLD: the APASL Metabolic fAtty lIver DiseasE coNsortium (MAIDEN)","volume":"17","author":"George","year":"2023","journal-title":"Hepatol Int"},{"issue":"11 November","key":"10.1016\/j.jgeb.2026.100733_bb0080","first-page":"1","article-title":"Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serumbased markers: A pilot study","volume":"16","author":"Goyale","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.jgeb.2026.100733_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-5926-6-7","article-title":"Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options","volume":"6","author":"Gressner","year":"2007","journal-title":"Comp Hepatol"},{"issue":"May","key":"10.1016\/j.jgeb.2026.100733_bb0090","article-title":"Non-alcoholic fatty liver disease related knowledge among a sample of Egyptians: an exploratory cross-sectional study","volume":"11","author":"Hegazy","year":"2023","journal-title":"Front Public Health"},{"issue":"03","key":"10.1016\/j.jgeb.2026.100733_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4236\/ojgas.2016.63008","article-title":"PNPLA3 and TNF-\u03b1 G238A genetic polymorphisms in Egyptian patients with different grades of severity of NAFLD","volume":"06","author":"Hegazy","year":"2016","journal-title":"Open J Gastroenterol"},{"issue":"21","key":"10.1016\/j.jgeb.2026.100733_bb0100","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.21037\/atm-20-2951","article-title":"Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance","volume":"8","author":"Jeong","year":"2020","journal-title":"Ann Transl Med"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100733_bb0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10549-020-05670-x","article-title":"Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival","volume":"182","author":"Joseph","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100733_bb0110","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jhep.2013.12.022","article-title":"MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury","volume":"60","author":"Kato","year":"2014","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100733_bb0115","first-page":"56","article-title":"Matrix metalloproteinase-9 as a marker for plaque rupture and a predictor of adverse clinical outcome in patients with acute coronary syndrome: an optical coherence tomography study","volume":"135","author":"Kobayashi","year":"2016","journal-title":"Cardiology (Switzerland)"},{"key":"10.1016\/j.jgeb.2026.100733_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3872367","article-title":"The role of matrix metalloproteinase-9 in atherosclerotic plaque instability","volume":"2020","author":"Li","year":"2020","journal-title":"Mediators Inflamm"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100733_bb0125","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2406173","article-title":"Non-alcoholic fatty liver disease, atherosclerosis, and cardiovascular disease in Asia","volume":"24","author":"Lim","year":"2023","journal-title":"Rev Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100733_bb0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/dc20-1997","article-title":"Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening","volume":"44","author":"Lomonaco","year":"2021","journal-title":"Diabetes Care"},{"issue":"September 2024","key":"10.1016\/j.jgeb.2026.100733_bb0135","first-page":"1","article-title":"Evaluation of the association between the PNPLA3 rs738409 variants with the incidence of atherosclerosis in patients with different fatty liver grades","volume":"38","author":"Mohamed","year":"2025","journal-title":"Gene Rep"},{"issue":"13","key":"10.1016\/j.jgeb.2026.100733_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310649","article-title":"Roles of matrix metalloproteinases and their natural inhibitors in metabolism: insights into health and disease","volume":"24","author":"Moli\u00e8re","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100733_bb0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep.24624","article-title":"Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients","volume":"55","author":"Myers","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jgeb.2026.100733_bb0150","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/biom12060824","article-title":"NAFLD: mechanisms, treatments, and biomarkers","volume":"12","author":"Nassir","year":"2022","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.jgeb.2026.100733_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113946","article-title":"Matrix metalloproteinases as biomarkers of atherosclerotic plaque instability","volume":"21","author":"Olejarz","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100733_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-022-01483-y","article-title":"The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study","volume":"21","author":"Park","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jgeb.2026.100733_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-10-67","article-title":"Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)","volume":"10","author":"Raszeja-Wyszomirska","year":"2010","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100733_bb0170","doi-asserted-by":"crossref","first-page":"29757","DOI":"10.1038\/s41598-024-68758-0","article-title":"Evaluation of tumorigenesis-related miRNAs in breast cancer in Egyptian women: a retrospective, exploratory analysis","volume":"14","author":"Salum","year":"2024","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100733_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2024.116331","article-title":"Comprehensive assessment of circulatory miRNAs as potential diagnostic markers in HCV recurrence post liver transplantation","volume":"109","author":"Salum","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"January","key":"10.1016\/j.jgeb.2026.100733_bb0180","first-page":"1","article-title":"MAFLD\/NAFLD biopsy-free scoring systems for hepatic steatosis, NASH, and fibrosis diagnosis","volume":"8","author":"Segura-Azuara","year":"2022","journal-title":"Front Med"},{"issue":"29","key":"10.1016\/j.jgeb.2026.100733_bb0185","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.3748\/wjg.v22.i29.6742","article-title":"Genetic factors that affect nonalcoholic fatty liver disease: a systematic clinical review","volume":"22","author":"Severson","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100733_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0066277","article-title":"Correlation of circulating MMP-9 with white blood cell count in humans: effect of smoking","volume":"8","author":"Snitker","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jgeb.2026.100733_bb0195","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-9212-2_34-1","article-title":"Imaging of carotid atherosclerosis","volume":"1\u201322","author":"Sun","year":"2014","journal-title":"Neurovasc Imaging"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100733_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjgast-2021-000780","article-title":"Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt","volume":"8","author":"Tomah","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100733_bb0205","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4239\/wjd.v8.i4.120","article-title":"World journal of management","volume":"8","author":"Trikkalinou","year":"2017","journal-title":"World J Diabetes"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100733_bb0210","first-page":"135","article-title":"Assessment of non-alcoholic fatty liver disease by non-invasive methods: present and future perspectives","volume":"83","author":"Vidal-Gonz\u00e1lez","year":"2020","journal-title":"Rev Med Hosp Gen M\u00e9x"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100733_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-022-01764-1","article-title":"Fatty acid-binding protein-4 (FABP4) and matrix metalloproteinase-9 (MMP9) as predictive values for nonalcoholic steatohepatitis (NASH)","volume":"22","author":"Wagner","year":"2023","journal-title":"Lipids Health Dis"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100733_bb0220","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/HJH.0000000000003394","article-title":"Predictive value of liver fibrosis scores in cardiovascular diseases among hypertensive population","volume":"41","author":"Xiong","year":"2023","journal-title":"J Hypertens"},{"issue":"April","key":"10.1016\/j.jgeb.2026.100733_bb0225","article-title":"Molecular mechanisms from the transition of MASLD-MASH-liver fibrosis to liver cancer","volume":"3","author":"Zhang","year":"2025","journal-title":"J Precis Med Health Dis"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100733_bb0230","first-page":"1","article-title":"Transcriptomics reveal a molecular signature in the progression of nonalcoholic steatohepatitis and identifies PAI-1 and MMP-9 as biomarkers in in vivo and in vitro studies","volume":"29","author":"Zhao","year":"2024","journal-title":"Mol Med Rep"},{"issue":"23","key":"10.1016\/j.jgeb.2026.100733_bb0235","doi-asserted-by":"crossref","first-page":"23996","DOI":"10.1074\/jbc.M311668200","article-title":"Engagement of \u03b1v\u03b23 integrin regulates proliferation and apoptosis of hepatic stellate cells","volume":"279","author":"Zhou","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26000776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26000776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:58:08Z","timestamp":1789559888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X26000776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1687157X26000776"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100733","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MMP-9 and non-invasive markers in evaluating MASLD and atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100733"}}